Bridging science and health policy in cardiovascular disease: focus on lipid management: A Report from a Session held during the 7th International Symposium on Multiple Risk Factors in Cardiovascular Diseases: Prevention and Intervention--Health Policy, in Venice, Italy, on 25 October, 2008.

In Europe, cardiovascular disease (CVD) represents the main cause of morbidity and mortality, costing countries euro 190 billion yearly (2006). CVD prevention remains unsatisfactory across Europe largely due to poor control of CVD risk factors (RFs), growing incidence of obesity and diabetes, and se...

Full description

Bibliographic Details
Main Authors: Atella, V, Brady, A, Catapano, A, Critchley, J, Graham, I, Hobbs, F, Leal, J, Lindgren, P, Vanuzzo, D, Volpe, M, Wood, D, Paoletti, R
Format: Journal article
Language:English
Published: 2009
_version_ 1797079234914549760
author Atella, V
Brady, A
Catapano, A
Critchley, J
Graham, I
Hobbs, F
Leal, J
Lindgren, P
Vanuzzo, D
Volpe, M
Wood, D
Paoletti, R
author_facet Atella, V
Brady, A
Catapano, A
Critchley, J
Graham, I
Hobbs, F
Leal, J
Lindgren, P
Vanuzzo, D
Volpe, M
Wood, D
Paoletti, R
author_sort Atella, V
collection OXFORD
description In Europe, cardiovascular disease (CVD) represents the main cause of morbidity and mortality, costing countries euro 190 billion yearly (2006). CVD prevention remains unsatisfactory across Europe largely due to poor control of CVD risk factors (RFs), growing incidence of obesity and diabetes, and sedentary lifestyle/poor dietary habits. Hypercholesterolaemia is a proven CVD RF, and LDL-C lowering slows atherosclerotic progression and reduces major coronary events. Lipid-lowering therapy is cost-effective, and intensive treatment of high-risk patients further improves cost effectiveness. In Italy, models indicate that improved cholesterol management translates into potential yearly savings of euro 2.9-4 billion. Identifying and eliminating legislative and administrative barriers is essential to providing optimal lipid care to high-risk patients. Public health and government policy can influence clinical practice rapidly, and guideline endorsement via national health policy may reduce the CVD burden and change physician and patient behaviour. Action to reduce CVD burden should ideally include the integration of strategies to lower the incidence of major CV events, improvement in total CV risk estimation, database monitoring of CVD trends, and development of population educational initiatives on CVD prevention. Failure to bridge the gap between science and health policy, particularly in relation to lipid management, could result in missed opportunities to reverse the burgeoning epidemic of CVD in Europe.
first_indexed 2024-03-07T00:42:52Z
format Journal article
id oxford-uuid:83a6a485-f7b9-472a-a6c9-94acf35620e3
institution University of Oxford
language English
last_indexed 2024-03-07T00:42:52Z
publishDate 2009
record_format dspace
spelling oxford-uuid:83a6a485-f7b9-472a-a6c9-94acf35620e32022-03-26T21:45:42ZBridging science and health policy in cardiovascular disease: focus on lipid management: A Report from a Session held during the 7th International Symposium on Multiple Risk Factors in Cardiovascular Diseases: Prevention and Intervention--Health Policy, in Venice, Italy, on 25 October, 2008.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:83a6a485-f7b9-472a-a6c9-94acf35620e3EnglishSymplectic Elements at Oxford2009Atella, VBrady, ACatapano, ACritchley, JGraham, IHobbs, FLeal, JLindgren, PVanuzzo, DVolpe, MWood, DPaoletti, RIn Europe, cardiovascular disease (CVD) represents the main cause of morbidity and mortality, costing countries euro 190 billion yearly (2006). CVD prevention remains unsatisfactory across Europe largely due to poor control of CVD risk factors (RFs), growing incidence of obesity and diabetes, and sedentary lifestyle/poor dietary habits. Hypercholesterolaemia is a proven CVD RF, and LDL-C lowering slows atherosclerotic progression and reduces major coronary events. Lipid-lowering therapy is cost-effective, and intensive treatment of high-risk patients further improves cost effectiveness. In Italy, models indicate that improved cholesterol management translates into potential yearly savings of euro 2.9-4 billion. Identifying and eliminating legislative and administrative barriers is essential to providing optimal lipid care to high-risk patients. Public health and government policy can influence clinical practice rapidly, and guideline endorsement via national health policy may reduce the CVD burden and change physician and patient behaviour. Action to reduce CVD burden should ideally include the integration of strategies to lower the incidence of major CV events, improvement in total CV risk estimation, database monitoring of CVD trends, and development of population educational initiatives on CVD prevention. Failure to bridge the gap between science and health policy, particularly in relation to lipid management, could result in missed opportunities to reverse the burgeoning epidemic of CVD in Europe.
spellingShingle Atella, V
Brady, A
Catapano, A
Critchley, J
Graham, I
Hobbs, F
Leal, J
Lindgren, P
Vanuzzo, D
Volpe, M
Wood, D
Paoletti, R
Bridging science and health policy in cardiovascular disease: focus on lipid management: A Report from a Session held during the 7th International Symposium on Multiple Risk Factors in Cardiovascular Diseases: Prevention and Intervention--Health Policy, in Venice, Italy, on 25 October, 2008.
title Bridging science and health policy in cardiovascular disease: focus on lipid management: A Report from a Session held during the 7th International Symposium on Multiple Risk Factors in Cardiovascular Diseases: Prevention and Intervention--Health Policy, in Venice, Italy, on 25 October, 2008.
title_full Bridging science and health policy in cardiovascular disease: focus on lipid management: A Report from a Session held during the 7th International Symposium on Multiple Risk Factors in Cardiovascular Diseases: Prevention and Intervention--Health Policy, in Venice, Italy, on 25 October, 2008.
title_fullStr Bridging science and health policy in cardiovascular disease: focus on lipid management: A Report from a Session held during the 7th International Symposium on Multiple Risk Factors in Cardiovascular Diseases: Prevention and Intervention--Health Policy, in Venice, Italy, on 25 October, 2008.
title_full_unstemmed Bridging science and health policy in cardiovascular disease: focus on lipid management: A Report from a Session held during the 7th International Symposium on Multiple Risk Factors in Cardiovascular Diseases: Prevention and Intervention--Health Policy, in Venice, Italy, on 25 October, 2008.
title_short Bridging science and health policy in cardiovascular disease: focus on lipid management: A Report from a Session held during the 7th International Symposium on Multiple Risk Factors in Cardiovascular Diseases: Prevention and Intervention--Health Policy, in Venice, Italy, on 25 October, 2008.
title_sort bridging science and health policy in cardiovascular disease focus on lipid management a report from a session held during the 7th international symposium on multiple risk factors in cardiovascular diseases prevention and intervention health policy in venice italy on 25 october 2008
work_keys_str_mv AT atellav bridgingscienceandhealthpolicyincardiovasculardiseasefocusonlipidmanagementareportfromasessionheldduringthe7thinternationalsymposiumonmultipleriskfactorsincardiovasculardiseasespreventionandinterventionhealthpolicyinveniceitalyon25october2008
AT bradya bridgingscienceandhealthpolicyincardiovasculardiseasefocusonlipidmanagementareportfromasessionheldduringthe7thinternationalsymposiumonmultipleriskfactorsincardiovasculardiseasespreventionandinterventionhealthpolicyinveniceitalyon25october2008
AT catapanoa bridgingscienceandhealthpolicyincardiovasculardiseasefocusonlipidmanagementareportfromasessionheldduringthe7thinternationalsymposiumonmultipleriskfactorsincardiovasculardiseasespreventionandinterventionhealthpolicyinveniceitalyon25october2008
AT critchleyj bridgingscienceandhealthpolicyincardiovasculardiseasefocusonlipidmanagementareportfromasessionheldduringthe7thinternationalsymposiumonmultipleriskfactorsincardiovasculardiseasespreventionandinterventionhealthpolicyinveniceitalyon25october2008
AT grahami bridgingscienceandhealthpolicyincardiovasculardiseasefocusonlipidmanagementareportfromasessionheldduringthe7thinternationalsymposiumonmultipleriskfactorsincardiovasculardiseasespreventionandinterventionhealthpolicyinveniceitalyon25october2008
AT hobbsf bridgingscienceandhealthpolicyincardiovasculardiseasefocusonlipidmanagementareportfromasessionheldduringthe7thinternationalsymposiumonmultipleriskfactorsincardiovasculardiseasespreventionandinterventionhealthpolicyinveniceitalyon25october2008
AT lealj bridgingscienceandhealthpolicyincardiovasculardiseasefocusonlipidmanagementareportfromasessionheldduringthe7thinternationalsymposiumonmultipleriskfactorsincardiovasculardiseasespreventionandinterventionhealthpolicyinveniceitalyon25october2008
AT lindgrenp bridgingscienceandhealthpolicyincardiovasculardiseasefocusonlipidmanagementareportfromasessionheldduringthe7thinternationalsymposiumonmultipleriskfactorsincardiovasculardiseasespreventionandinterventionhealthpolicyinveniceitalyon25october2008
AT vanuzzod bridgingscienceandhealthpolicyincardiovasculardiseasefocusonlipidmanagementareportfromasessionheldduringthe7thinternationalsymposiumonmultipleriskfactorsincardiovasculardiseasespreventionandinterventionhealthpolicyinveniceitalyon25october2008
AT volpem bridgingscienceandhealthpolicyincardiovasculardiseasefocusonlipidmanagementareportfromasessionheldduringthe7thinternationalsymposiumonmultipleriskfactorsincardiovasculardiseasespreventionandinterventionhealthpolicyinveniceitalyon25october2008
AT woodd bridgingscienceandhealthpolicyincardiovasculardiseasefocusonlipidmanagementareportfromasessionheldduringthe7thinternationalsymposiumonmultipleriskfactorsincardiovasculardiseasespreventionandinterventionhealthpolicyinveniceitalyon25october2008
AT paolettir bridgingscienceandhealthpolicyincardiovasculardiseasefocusonlipidmanagementareportfromasessionheldduringthe7thinternationalsymposiumonmultipleriskfactorsincardiovasculardiseasespreventionandinterventionhealthpolicyinveniceitalyon25october2008